Showing 1 - 20 results of 5,093 for search '(( design ((teer decrease) OR (a decrease)) ) OR ( a ((largest decrease) OR (marked decrease)) ))', query time: 0.51s Refine Results
  1. 1
  2. 2
  3. 3

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

    Published 2024
    “…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Orthogonal experimental design. by Yining Wang (432154)

    Published 2025
    “…Fatigue test results reveal that the ZM modifier markedly extends fatigue life, with a maximum increase of 128.9%, and reduces fatigue sensitivity to the stress ratio. …”
  15. 15

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
  16. 16

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
  17. 17

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
  18. 18

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
  19. 19

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
  20. 20

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”